Anti-infective Drugs Advisory Committee
Executive Summary
Will meet Sept. 23 to discuss surrogate markers, such as pharmacokinetic parameters and microbiological inhibitory and vital data, and whether such parameters can be used instead of clinical efficacy data to support an alternative dosing regimen for oral metronidazole in the treatment of Trichomonas vaginalis vaginitis. The committee will meet at the Holiday Inn in Silver Spring, Md. at 8 a.m